Biotechnology
NeuroVive Pharmaceutical AB Interim Report January - June 2019
STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...
2019-08-21 15:24
7890
WuXi Biologics Reports Outstanding Interim Results
* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Year to RMB449.5 Million * Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Record High * Total Backlog Surged to US$4.6 Billion * 32 New Integrated Projects Including 1...
2019-08-19 22:09
10892
WuXi AppTec Reports First Half 2019 Interim Results
* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...
2019-08-19 19:20
5277
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress
SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...
2019-08-19 13:50
6139
Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones
Customers Choose from a Wider Spectrum of Flavor Profiles BOSTON, Aug. 13, 2019 /PRNewswire/ -- Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalact...
2019-08-13 03:47
3457
Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers
Pharmaceuticals, biotechnology, and academics emerge major adopters of analytical equipment, finds Frost & Sullivan SANTA CLARA, California, Aug. 13, 2019 /PRNewswire/ -- The rise of the Industrial Internet of Things (IIoT) has given a significant boost to the global analytical instrumentation ma...
2019-08-13 00:19
2433
New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.
SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study onFrontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncoty...
2019-08-12 21:00
2481
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application
INCHEON, South Korea, Aug. 12, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 facility at its manufacturing site in Songdo, S. Korea rec...
2019-08-12 19:00
2083
The iQ Group Global named one of Australia's Top 5 Most Innovative Companies 2019
SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global
2019-08-09 18:46
2313
OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial
STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial p...
2019-08-09 14:57
2200
EnGeneIC Wins Innovation Award from Australian Financial Review
Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targe...
2019-08-09 12:49
1901
DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease
SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first patients have been ...
2019-08-07 21:00
2073
Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies
YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning diseas...
2019-08-07 10:30
8010
LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI)
CAMBRIDGE, Massachusetts, Aug. 6, 2019 /PRNewswire/ -- LUCA Biologics, a biotechnology company co-founded by Dr.Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist. The company's fir...
2019-08-06 18:00
2050
China Biologic Reports Financial Results for the Second Quarter of 2019
--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAA...
2019-08-06 04:30
8343
Ascletis Received IND Approval and Management Outlook of 2019 and Beyond
HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...
2019-08-05 08:00
3567
ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019
LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...
2019-08-01 04:39
1971
Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution
SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...
2019-07-29 21:42
5488
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets
REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...
2019-07-29 12:00
5594
NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation
LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...
2019-07-28 21:47
5636
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 316 media titles]
2024-06-25 21:00
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15576
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13163
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9412
